Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04160975 · ClinicalTrials.gov registry record · NA

Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects

A NA study, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
3,245
Enrollment target

NCT04160975 is a NA study that has completed, run by Harvard University. The registered enrollment target is 3,245 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04160975, a NA study, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
3,245 participants
Enrollment target

Study Summary

The aim of the study is to identify what sender/signal combinations are most persuasive in encouraging low socioeconomic males living in the U.S. to take-up seasonal flu vaccination. The investigators plan to recruit male subjects and randomly assign them to four persuasion treatments: three of which vary dimensions of the sender of a medical recommendation (racial concordance and authority treatments) and one which varies the signal (standard vs. empathetic). Specifically, the investigators will show subjects videos of either Black or white actors/actresses providing scripted information on the flu vaccination. The investigators will randomize the race of the sender and if the subject is Black, also randomize the authority of the sender, with the actor portraying either a doctor or a layperson. In addition, the investigators will vary the script used in the experiment between one that acknowledges past injustices (indicated as an empathetic script hereafter) and one that does not (indicated as a standard script hereafter). The investigators will provide subjects a free flu shot coupon and elicit the price at which subjects would be willing to give up this coupon for a cash reward. Lastly, in light of the relevance of vaccination take-up in combating COVID-19 pandemic, the investigators will assess demand for information about a COVID-19 vaccine, with subjects invited to receive results of a safety and efficacy review from a trusted or standard source. The design requires the collection of baseline and endline surveys combined with administrative data from pharmacies about coupon redemption. The primary outcomes of interest are posterior beliefs about seasonal flu vaccination, demand and willingness-to-pay (WTP) for a free flu shot coupon, redemption of the coupon, and demand for information about a COVID-19 vaccine.

Interventions

  • BEHAVIORAL Video about safety and effectiveness of adult seasonal flu vaccination

Trial Details

FieldValue
Enrollment Target 3,245 participants
Start Date 2019-12-20
Est. Completion 2021-02-19
Phase NA

Sponsor

Harvard University

37 total trials

What the Registry Record Tells You About NCT04160975

The ClinicalTrials.gov registry entry for NCT04160975 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,245 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Video about safety and effectiveness of adult seasonal flu vaccination is the first listed.

NCT04160975 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04160975 about?

NCT04160975 is a clinical study titled "Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects". The aim of the study is to identify what sender/signal combinations are most persuasive in encouraging low socioeconomic males living in the U.S. to take-up seasonal flu vaccination. The investigators plan to recruit male subjects and randomly assign them to four persuasion treatments: three of whic...

What is the current status of trial NCT04160975?

This trial is currently completed. It is a NA study. The enrollment target is 3,245 participants. The study started on 2019-12-20. Estimated completion is 2021-02-19.

What interventions are being tested in trial NCT04160975?

The interventions under investigation include: Video about safety and effectiveness of adult seasonal flu vaccination (BEHAVIORAL).

Who is sponsoring clinical trial NCT04160975?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.